AICure is the pioneer in AI and advanced data analytics for medical adherence. Our platform verifies protocol adherence, monitors patient behavior, and enables remote patient engagement in clinical trials. Built for modern, patient-centered research, AICure delivers actionable insights that help study teams identify adherence risks early and intervene when it matters most. Our technology brings greater visibility to the patient experience beyond the site, supporting higher-quality data and more confident trial decisions, ultimately reducing costs and accelerating trial timelines. Founded in 2010 and funded by the National Institutes of Health (NIH) and leading institutional investors, AICure has more than 90 issued patents and works with global clients in over 50 countries. AICure is globally recognized and is a recipient of the Scrip Award, AI 100, and Digital Health 150. For more information, please visit www.aicure.com.
Looking for a particular AiCure employee's phone or email?
The AiCure annual revenue was $14.1 million in 2026.
Sabina Chadha is the CEO of AiCure.
30 people are employed at AiCure.
AiCure is based in Houston, Texas.
The NAICS codes for AiCure are [334, 33].
The SIC codes for AiCure are [38, 384, 737, 73].